Literature DB >> 27259938

An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.

Ilmari Pyykkö1,2, Jing Zou3, Annelies Schrott-Fischer4, Rudolf Glueckert4, Paavo Kinnunen5.   

Abstract

Nanoparticles offer new possibilities for inner ear treatment as they can carry a variety of drugs, protein, and nucleic acids to inner ear. Nanoparticles are equipped with several functions such as targetability, immuno-transparency, biochemical stability, and ability to be visualized in vivo and in vitro. A group of novel peptides can be attached to the surface of nanoparticles that will enhance the cell entry, endosomal escape, and nuclear targeting. Eight different types of nanoparticles with different payload carrying strategies are available now. The transtympanic delivery of nanoparticles indicates that, depending on the type of nanoparticle, different migration pathways into the inner ear can be employed, and that optimal carriers can be designed according to the intended cargo. The use of nanoparticles as drug/gene carriers is especially attractive in conjunction with cochlear implantation or even as an inclusion in the implant as a drug/gene reservoir.

Keywords:  Gene therapy; Growth factor delivery; Repair of inner ear; Targeted drug delivery

Mesh:

Year:  2016        PMID: 27259938     DOI: 10.1007/978-1-4939-3615-1_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Association between Syncope and Tumarkin Attacks in Ménière's Disease.

Authors:  Ilmari Pyykkö; Vinaya Manchaiah; Jing Zou; Hilla Levo; Erna Kentala
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

Review 2.  Nanomedicine for Inner Ear Diseases: A Review of Recent In Vivo Studies.

Authors:  Dong-Kee Kim
Journal:  Biomed Res Int       Date:  2017-10-10       Impact factor: 3.411

3.  Acquired sensorineural hearing loss in children: current research and therapeutic perspectives.

Authors:  M Ralli; R Rolesi; R Anzivino; R Turchetta; A R Fetoni
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-12       Impact factor: 2.124

Review 4.  NANOCI-Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons.

Authors:  Pascal Senn; Marta Roccio; Stefan Hahnewald; Claudia Frick; Monika Kwiatkowska; Masaaki Ishikawa; Peter Bako; Hao Li; Fredrik Edin; Wei Liu; Helge Rask-Andersen; Ilmari Pyykkö; Jing Zou; Marika Mannerström; Herbert Keppner; Alexandra Homsy; Edith Laux; Miguel Llera; Jean-Paul Lellouche; Stella Ostrovsky; Ehud Banin; Aharon Gedanken; Nina Perkas; Ute Wank; Karl-Heinz Wiesmüller; Pavel Mistrík; Heval Benav; Carolyn Garnham; Claude Jolly; Filippo Gander; Peter Ulrich; Marcus Müller; Hubert Löwenheim
Journal:  Otol Neurotol       Date:  2017-09       Impact factor: 2.311

Review 5.  The Use of Nanoparticles in Otoprotection.

Authors:  Maurizio Barbara; Valerio Margani; Edoardo Covelli; Chiara Filippi; Luigi Volpini; Ola M El-Borady; Maged El-Kemary; Saad Elzayat; Haitham H Elfarargy
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

6.  Development and in vivo validation of small interfering RNAs targeting NOX3 to prevent sensorineural hearing loss.

Authors:  German Nacher-Soler; Antoine Marteyn; Natasha Barenzung; Stéphanie Sgroi; Karl-Heinz Krause; Pascal Senn; Francis Rousset
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

Review 7.  Presbycusis: An Update on Cochlear Mechanisms and Therapies.

Authors:  Jing Wang; Jean-Luc Puel
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.